MedPath

Pediatric Ilioinguinal / Iliohyogogastric Nerve Block

Not Applicable
Conditions
Intra-operative Anesthesia and Analgesia Effects
Interventions
Registration Number
NCT02990884
Lead Sponsor
Erzincan University
Brief Summary

Ilioinguinal / iliohyogogastric nerve blocks; It is frequently used for analgesia and anesthesia in inguinal region surgeons. However, 95% of these surgeons are under general anesthesia. aim of this study; Intra-operative anesthesia and analgesia effects of ilioinguinal / iliohyogogastric nerve block supported by ketamine sedation only.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ASA I-II
  • To undergo elective lower abdominal surgery
  • between 2-6 years old
Exclusion Criteria
  • Patients with psychiatric disease
  • Patients whose weight is more than 40 kg
  • Patients with cardiac-pulmonary-neurological disease
  • Patients with bleeding disorder
  • Patients with infection or scar on the injection area
  • Patients with known allergies to local anesthetics

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ketamine atropine; laryngeal maskketamineAfter ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane MAC and oxygen / air mixture and applied Ilioinguinal / iliohypogastric block.
block and ketamineketamineIlioinguinal / iliohypogastric block after ketamine atropine induction and continued with ketamine only in anesthesia
control groupketamineAfter ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane MAC and oxygen / air mixture and Non-block, postoperative analgesia with paracetamol IV
Primary Outcome Measures
NameTimeMethod
the amount of anesthetic drug which was usednine month
Secondary Outcome Measures
NameTimeMethod
Postoperative visual analogue scalenine month

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.